Source comparison
Combine GHK-Cu Epithalon Synergy Dosing Timing: Protocol Comparison
Synergistic Co-Administration 2mg daily SubQ 10mg daily SubQ Epithalon injected first; GHK-Cu 15–30 min later, different site 10 days (Epithalon) + 4–8 weeks (GHK-Cu continues) Maximizes metabolic overlap window; allows full telomerase activation cycle while s
This comparison does not assign a generated winner or score.
- Synergistic Co-Administration
- 2mg daily SubQ
- 10mg daily SubQ
- Epithalon injected first; GHK-Cu 15–30 min later, different site
- 10 days (Epithalon) + 4–8 weeks (GHK-Cu continues)
- Maximizes metabolic overlap window; allows full telomerase activation cycle while sustaining tissue repair effects beyond Epithalon pulse
- Sequential Protocol
- 2–3mg daily SubQ
- 5–10mg daily SubQ
- GHK-Cu morning; Epithalon evening (6+ hours apart)
- 10 days concurrent, then GHK-Cu solo
- Eliminates any theoretical absorption competition; useful if injection site availability is limited or local reactions occur
- Alternating Days
- 3mg every other day
- 10mg every other day
- Opposite days (e.g., GHK-Cu Mon/Wed/Fri; Epithalon Tue/Thu/Sat)
- 2–3 weeks
- Reduces injection frequency; loses synergistic plasma overlap but maintains independent pathway activation. Suitable for needle-averse researchers
- Extended GHK-Cu with Pulsed Epithalon
- 1–2mg daily SubQ
- 10mg daily SubQ for 10 days only
- GHK-Cu runs 8–12 weeks continuously; Epithalon added as 10-day pulse at weeks 1, 5, 9
- 8–12 weeks total
- Mirrors natural tissue repair timelines (sustained collagen remodeling) with periodic telomerase stimulation. Best-documented longevity protocol structure